Keyphrases
Membranous Nephropathy
100%
Fludarabine
100%
Proteinuria
66%
Lymphopenia
33%
Filtration Fraction
33%
High Dose
16%
Lymphocytes
16%
T Cells
16%
B Cells
16%
Lupus
16%
Cell Count
16%
Cyclosporine
16%
CD8+ T Cells
16%
Antibiotic Therapy
16%
Patient-completed
16%
Clinical Efficacy
16%
Disease Duration
16%
CD45RA
16%
Prednisone
16%
End of Treatment
16%
CD4 Cells
16%
Immunological Effects
16%
Clinical Effect
16%
Pharmacokinetic Effects
16%
Serum Immunoglobulin Levels
16%
Optimal Dose
16%
CD45RO
16%
Alkylating Agents
16%
Memory CD4+ T Cells
16%
Filtration Efficiency
16%
Monthly Cycle
16%
Toxicity Effects
16%
Effective Renal Plasma Flow
16%
Resting Lymphocytes
16%
Selective Activity
16%
Tolerance Effect
16%
Acute Bacterial Sinusitis
16%
Purine nucleoside Analogues
16%
Immunology and Microbiology
Low Drug Dose
100%
Membranous Glomerulonephritis
100%
Lymphocyte
40%
Lymphocytopenia
40%
Arm
20%
Drug Megadose
20%
T Cell
20%
B Cell
20%
CD3 Antigen
20%
CD4
20%
Immunoglobulin Blood Level
20%
T-Helper Cell
20%
CD8
20%
Cell Count
20%
Prednisone
20%
Pharmacokinetics
20%
Ciclosporin
20%
Lupus Erythematosus
20%
Sinusitis
20%
Optimal Drug Dose
20%
Effective Kidney Plasma Flow
20%
Pharmacology, Toxicology and Pharmaceutical Science
Fludarabine
100%
Membranous Glomerulonephritis
100%
Proteinuria
66%
Lymphocytopenia
33%
Disease
16%
Antibiotic Therapy
16%
Side Effect
16%
Pharmacokinetics
16%
Prednisone
16%
CD8 Antigen
16%
Ciclosporin
16%
Immunoglobulin
16%
Alkylating Agent
16%
Purine Nucleoside Derivative
16%
Bacterial Sinusitis
16%
Biochemistry, Genetics and Molecular Biology
Low Drug Dose
100%
Fludarabine
100%
T Cell
33%
CD4
33%
Lymphocyte
33%
Drug Megadose
16%
B Cell
16%
CD8
16%
Prednisone
16%
Pharmacokinetics
16%
Ciclosporin
16%
Cell Count
16%
Nucleoside Analogue
16%
Immunoglobulin Blood Level
16%
Optimal Drug Dose
16%
Effective Kidney Plasma Flow
16%